Genertec Universal Medical Stock Fundamentals
| 5UM Stock | EUR 0.57 0.01 1.72% |
Genertec Universal Medical fundamentals help investors to digest information that contributes to Genertec Universal's financial success or failures. It also enables traders to predict the movement of Genertec Stock. The fundamental analysis module provides a way to measure Genertec Universal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genertec Universal stock.
Genertec |
Genertec Universal Medical Company Current Valuation Analysis
Genertec Universal's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Genertec Universal Current Valuation | 7.33 B |
Most of Genertec Universal's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genertec Universal Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Genertec Universal Medical has a Current Valuation of 7.33 B. This is 62.03% lower than that of the Technology sector and 199.01% higher than that of the Health Information Services industry. The current valuation for all Germany stocks is 55.89% higher than that of the company.
Genertec Universal Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genertec Universal's current stock value. Our valuation model uses many indicators to compare Genertec Universal value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genertec Universal competition to find correlations between indicators driving Genertec Universal's intrinsic value. More Info.Genertec Universal Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.24 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genertec Universal Medical is roughly 4.13 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genertec Universal's earnings, one of the primary drivers of an investment's value.Genertec Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genertec Universal's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genertec Universal could also be used in its relative valuation, which is a method of valuing Genertec Universal by comparing valuation metrics of similar companies.Genertec Universal is currently under evaluation in current valuation category among its peers.
Genertec Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0283 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 7.33 B | |||
| Shares Outstanding | 1.89 B | |||
| Shares Owned By Insiders | 54.91 % | |||
| Shares Owned By Institutions | 4.24 % | |||
| Price To Earning | 5.44 X | |||
| Price To Book | 0.51 X | |||
| Price To Sales | 0.10 X | |||
| Revenue | 9.91 B | |||
| Gross Profit | 3.85 B | |||
| EBITDA | 3.04 B | |||
| Net Income | 1.95 B | |||
| Cash And Equivalents | 266.78 M | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 28.65 B | |||
| Debt To Equity | 321.90 % | |||
| Current Ratio | 3.36 X | |||
| Book Value Per Share | 7.91 X | |||
| Cash Flow From Operations | (1.4 B) | |||
| Earnings Per Share | 0.12 X | |||
| Number Of Employees | 18.08 K | |||
| Beta | 0.74 | |||
| Market Capitalization | 1.06 B | |||
| Total Asset | 69.9 B | |||
| Annual Yield | 0.08 % | |||
| Net Asset | 69.9 B | |||
| Last Dividend Paid | 0.29 |
About Genertec Universal Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genertec Universal Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genertec Universal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genertec Universal Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Genertec Universal Medical Group Company Limited provides integrated healthcare services with integration of capital, technology, equipment, specialists, management, and training resources to hospital customers in Mainland China and Hong Kong. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China. GENERTEC UNIVER operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 705 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Genertec Stock
Genertec Universal financial ratios help investors to determine whether Genertec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genertec with respect to the benefits of owning Genertec Universal security.